Alan Brochstein, Managing Partner at New Cannabis Ventures and Principal at 420 Investor, examines cannabis stocks. He discusses what investors have learned from Canopy Growth’s (CGC) earnings. He talks about Cronos’ (CRON) 2Q revenue which came in at $15.60M versus an estimated $18.08M. He also mentions AdvisorShares Trust Pure US Cannabis ETF (MSOS). Tune in to find out more.
06 Aug 2021
Next Gen Investing
30 Jun 2022
Next Gen Investing
15 Jul 2022
Next Gen Investing
22 Jun 2022
The Watch List
25 May 2022
Morning Trade Live
05 Aug 2022
The Watch List
05 Jul 2022